What are the most effective ways you can help patients stop smoking? by Shah, Zille Huma et al.
CLINICAL INQUIRIES Evidence Based Answers from the Family Physicians 
Inquiries Network
478 VOL 57, NO 7 / JULY 2008  THE JOURNAL OF FAMILY PRACTICE
FAST TRACK
  Evidence-based answer
Brief counseling, nicotine replacement 
therapy, antidepressants, and varenicline 
all work well. Physician intervention 
should begin with routine assessment 
of smoking status for all patients. Brief 
(3 minutes or less) smoking cessation 
counseling improves quit rates (strength 
of recommendation [SOR]: A, Cochrane 
systematic review). Nicotine replacement 
therapy (NRT), antidepressants (bupropion 
and nortriptyline), and the nicotine receptor 
partial agonist varenicline are effective 
and should be offered to help smokers 
quit (SOR: A, Cochrane systematic 
reviews and randomized controlled trials 
[RCTs]).
Clinical commentary
Ask and act
Physician counseling can help patients 
stop using tobacco. Medications, including 
NRT, increase abstinence rates even more. 
I fi nd the American Academy of Family 
Physicians’ smoking cessation program, 
“Ask and Act,” easier to use than the 
United States Public Health Services “5 
A’s” approach, which is described later in 
this Clinical Inquiry. 
 Several materials that support the Ask 
and Act program are available free online 
at www.aafp.org (click on “Ask and Act” 
under “Clinical Care & Research”). I have 
used the prescription sheet for smoking 
cessation when talking to patients about 
quitting; the coding reference gives some 
guidance about charging for cessation 
counseling. A prescribing guideline for 
medications, including side effects and 
contraindications, is also available. 
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❚ Evidence summary
Brief counseling works 
Good evidence suggests that physician-
administered smoking cessation counsel-
ing lasting less than 3 minutes improves 
quit rates.1 A Cochrane analysis of 
pooled data from 17 randomized trials 
that compared brief advice to no advice 
or usual care showed a small but sig-
nifi cant increase in the odds of smoking 
cessation (odds ratio [OR]=1.74; 95% 
confi dence interval [CI], 1.48-2.05).2 The 
absolute difference in cessation rate was 
about 2.5% (number needed to treat 
[NNT]=40). 
Another systematic review of 188 
RCTs concluded that an estimated 2% 
(95% CI, 1%-3%; P<.001) of all smokers 
stopped smoking and did not relapse for 
as long as a year after receiving advice and 
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encouragement to quit smoking from their 
physician in a single routine consultation.3 
NRT is effective and safe 
for heart patients
NRT reduces withdrawal symptoms as-
sociated with stopping smoking by par-
tially replacing nicotine in the blood. 
Abstinence rates are superior to placebo 
based on a Cochrane review (OR=1.77; 
95% CI, 1.66-1.88; NNT=20; 95% CI, 
17-23).4 The Cochrane review also con-
cluded that all commercially available 
forms of NRT are effective for smoking 
cessation. Also, recent studies have estab-
lished no association between NRT and 
further cardiac events.1 
Antidepressants 
are good treatment options
Bupropion acts by increasing brain levels 
of dopamine and norepinephrine and is a 
nicotine antagonist. A large double-blind, 
placebo controlled trial compared the 
relative effi cacy of sustained-release bu-
propion (n=244), nicotine patch (n=244), 
bupropion plus nicotine patch (n=245), 
and placebo (n=160).5 At 1 year, the bu-
propion groups had higher self-reported 
point-prevalence abstinence rates (absti-
nence during the previous 7 days) than the 
placebo and nicotine-patch-alone groups 
(bupropion 30%, placebo 16%, nicotine-
patch-alone 16%; absolute risk reduction 
[ARR]=0.14, NNT=7, P<.001). 
Continuous abstinence (abstinence 
from quit date) was also higher for the 
bupropion groups compared with pla-
cebo (bupropion 18%, placebo 6%; 
ARR=0.12; NNT=8; P<.001). Adding 
nicotine replacement to bupropion ther-
apy increased 1-year smoking cessation 
rates by 5% over bupropion alone but 
was not statistically signifi cant. 
A Cochrane review assessing the effi -
cacy of antidepressants for smoking ces-
sation showed that, when used as mono-
therapy, bupropion (31 trials; OR=1.94; 
95% CI, 1.72-2.19) and nortriptyline (4 
trials; OR=2.34; 95% CI, 1.61-3.41) both 
doubled the odds of smoking cessation.6
Another option: Varenicline
Varenicline, a partial agonist at the α4β2 nic-
otinic acetylcholine receptor, aids smoking 
cessation by relieving nicotine withdrawal 
symptoms. A Cochrane meta-analysis con-
cluded that varenicline resulted in signifi -
cantly greater continuous abstinence at 12 
months than placebo (OR=3.22; 95% CI, 
2.43-4.27; NNT=8; 95% CI, 5-11).7
Recommendations 
The US Preventive Service Task Force 
(USPSTF) strongly recommends that clini-
cians screen all adults for tobacco use and 
provide tobacco cessation interventions 
as needed.8 The USPSTF’s Clinical Prac-
tice Guideline for treating tobacco depen-
dence recommends following a 5-step (5 
A’s) intervention for smoking cessation in 
patients willing to quit.1 
1.  Ask the patient about smoking sta-
tus at every visit.
2. Advise the patient to stop smoking. 
3.  Assess the patient’s willingness to 
quit. 
4.  Assist the patient by setting a date 
to quit smoking, providing self-help 
materials, and recommending the 
use of pharmacologic agents.
5. Arrange for follow-up visits. ■
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